Insurance Coverage

Forbes - Mar 17th, 2025
Score 6.6

At Current Prices GLP-1s Aren’t Cost-Effective, Limiting Access To Patients

GLP-1 drugs like Wegovy not cost-effective, study finds.

Previous Next

Showing 1 to 1 of 1 results